OTC Markets OTCPK - Delayed Quote USD

GB Sciences, Inc. (GBLX)

0.0040

0.0000

(0.00%)

As of January 30 at 1:52:25 PM EST. Market Open.

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences

GB Sciences' Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences' Cannabinoid-based Treatments for a Suite of Neurological Disorders LAS VEGAS, NV / ACCESSWIRE / July 2, 2024 / GB Sciences, Inc. (OTCQB:GBLX), ...

ACCESS Newswire 6 months ago

GBLX
0.00%

Performance Overview

Return	GBLX	S&P 500
YTD	-4.76%	+3.41%
1-Year	-23.08%	+24.03%
3-Year	-86.71%	+37.83%